Human immunodeficiency virus and lymphoma

Bull Cancer. 2021 Jul 7:S0007-4551(21)00180-6. doi: 10.1016/j.bulcan.2021.03.014. Online ahead of print.ABSTRACTLymphomas remain a leading cause of morbidity and mortality for HIV-positive patients. The most common lymphomas include diffuse large B-cell lymphoma, Burkitt lymphoma, primary effusion lymphoma, plasmablastic lymphoma and Hodgkin lymphoma. Appropriate approach is determined by lymphoma stage, performans status, comorbidities, histological subtype, status of the HIV disease and immunosuppression. Treatment outcomes have improved due to chemotherapy modalities and effective antiretroviral therapy. This review summarizes epidemiology, pathogenesis, pathology, and current treatment landscape in HIV associated lymphoma.PMID:34246454 | DOI:10.1016/j.bulcan.2021.03.014
Source: Bulletin du Cancer - Category: Cancer & Oncology Authors: Source Type: research